You have 9 free searches left this month | for more free features.

Recurrent Prostate Cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Prostate Cancer Patients

Not yet recruiting
  • Recurrent Prostate Cancer
    • San Francisco, California
      Power Life Sciences
    Sep 30, 2023

    Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)

    Not yet recruiting
    • Prostate Cancer
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 27, 2023

    Biochemical Recurrent Prostate Cancer Trial run by the National Cancer Institute (NCI) (Radium-223, 18F Sodium Fluoride)

    Recruiting
    • Biochemical Recurrent Prostate Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

    Not yet recruiting
    • Prostate Cancer
    • Biochemically Recurrent
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Prostate Cancer Trial (PSMA-radioguided surgery, ADT)

    Not yet recruiting
    • Prostate Cancer
    • PSMA-radioguided surgery
    • ADT
    • (no location specified)
    Sep 22, 2022

    Prostate Cancer Trial run by the National Cancer Institute (NCI) (PROSTVAC-V, PROSTVAC-F, MSB0011359C (M7824))

    Recruiting
    • Prostate Cancer
    • PROSTVAC-V
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Prostate Tumors, Prostatic Cancer, Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, 18F-FDG,

    Enrolling by invitation
    • Prostate Neoplasms
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Recurrent Prostate Cancer After Surgery Trial in Rochester (Daily-adaptive Stereotactic Body Radiation Therapy)

    Not yet recruiting
    • Recurrent Prostate Cancer After Surgery
    • Daily-adaptive Stereotactic Body Radiation Therapy
    • Rochester, New York
      Wilmot Cancer Institute - Dept of Radiation Oncology
    Jul 7, 2023

    Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Beverly Hills, Los Angeles, Pasadena

    Active, not recruiting
    • Adenocarcinoma of the Prostate
    • +5 more
    • phenelzine sulfate
    • +2 more
    • Beverly Hills, California
    • +3 more
    Aug 19, 2022

    Prostate Cancer Trial in Boston, South Weymouth, Londonderry (Nivolumab)

    Recruiting
    • Prostate Cancer
    • Boston, Massachusetts
    • +4 more
    Dec 5, 2022

    Prostate Cancer Metastatic Trial in New York (Actinium-J591, Stereotactic Body Radiation Therapy, Androgen Deprivation Therapy)

    Not yet recruiting
    • Prostate Cancer Metastatic
    • New York, New York
      Weill Cornell Medicine - New York Presbyterian Hospital
    Oct 3, 2022

    Prostate Cancer Recurrent Trial in Toronto (HDR brachytherapy)

    Active, not recruiting
    • Prostate Cancer Recurrent
    • HDR brachytherapy
    • Toronto, Ontario, Canada
      Odette Cancer Centre, Sunnybrook Health Sciences Centre
    May 3, 2022

    Prostate Cancer, Prosatatic Tumor Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, Tumor Irradiation, Prostate +

    Recruiting
    • Prostate Cancer
    • Prosatatic Neoplasm
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 7, 2022

    Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Columbus (Arm I Soy Bread, Arm II Soy-Almond Bread)

    Active, not recruiting
    • Recurrent Prostate Cancer
    • Stage IV Prostate Cancer
    • Arm I Soy Bread
    • Arm II Soy-Almond Bread
    • Columbus, Ohio
      The Ohio State University Medical Center
    Apr 29, 2022

    Prostate Adenocarcinoma Trial (68Ga-PSMA-11)

    Available
    • Prostate Adenocarcinoma
    • (no location specified)
    Jun 10, 2022

    Prostate Cancer Trial in Poznan (brachytherapy)

    Recruiting
    • Prostate Cancer
    • brachytherapy
    • PoznaƄ, Greater Poland, Poland
      Greater Poland Cancer Centre / Brachytherapy Department
    Jan 27, 2023

    Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma, Prostate Adenocarcinoma Trial in Houston (Fluorine F

    Recruiting
    • Biochemically Recurrent Prostate Carcinoma
    • +2 more
    • Fluorine F 18 rhPSMA-7.3
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Prostate Cancer Trial in Toronto (SpaceOAR)

    Recruiting
    • Prostate Cancer
    • SpaceOAR
    • Toronto, Ontario, Canada
      Sunnybrook Odette Cancer Centre
    Oct 25, 2022

    Prostate Cancer Trial in Duarte, South Pasadena (white button mushroom extract, flow cytometry, immunologic technique)

    Completed
    • Prostate Cancer
    • white button mushroom extract
    • +5 more
    • Duarte, California
    • +1 more
    Mar 16, 2022

    PSMA-PET and MRI for Detection of Recurrent Prostate Cancer

    Recruiting
    • Prostatic Neoplasms
    • PSMA PET/CT
    • PSMA PET/MR
    • Bergen, Norway
    • +2 more
    Jun 9, 2022

    Recurrent Prostate Cancer Trial in Philadelphia, Toronto, London (Verteporfin, SpectraCure P18 System)

    Recruiting
    • Recurrent Prostate Cancer
    • New York, New York
    • +3 more
    Nov 15, 2022

    Prostate Cancer Trial in United States (Apalutamide, Androgen deprivation, Salvage radiation therapy)

    Active, not recruiting
    • Prostate Cancer
    • Omaha, Nebraska
    • +4 more
    Nov 10, 2022

    Prostate Cancer, Recurrent Prostate Cancer Trial in Tampa (F-DCFPyL Injection, PSMA PET)

    Recruiting
    • Prostate Cancer
    • Recurrent Prostate Cancer
    • F-DCFPyL Injection
    • PSMA PET
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 24, 2023

    PET-MR-PSA Prostate Cancer Recidive Study

    Active, not recruiting
    • Prostate Cancer Recurrent
      • Trondheim, Norway
        St Olavs Hospital, PET center
      Mar 1, 2022

      Prostate Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)

      Active, not recruiting
      • Prostate Cancer
      • Ad5-yCD/mutTKSR39rep-hIL12
      • Detroit, Michigan
        Henry Ford Health System
      Feb 17, 2022